Immunology Case Reports

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.
Reach Us +44 7480724769

Case Report - Immunology Case Reports (2020) Volume 4, Issue 1

Life-threatening atypical haemolytic uremic syndrome and cardiomyopathy related to novel CFHR3 mutation in a patient with lupus.

 A 50-year-old Bangladeshi female with a background of Lupus,  presented  with  biopsy  proven thrombotic microangiopathy. She underwent empiric plasma exchange with limited efficacy, subsequently her ADAMTS-13 activity retuned to be normal excluding thrombotic thrombocytopenic purpura. She was then treated with prednisolone, and Rituximab for a possible Lupus flare, with minimal response. Due to ongoing haemolysis and progressive kidney injury a diagnosis of atypical haemolytic uremic syndrome (aHUS) was made and Eculizumab therapy commenced. During her admission she developed new onset non-ischemic cardiomyopathy. It was thought her cardiomyopathy was related to her aHUS, and she underwent immunophenotyping and whole exome. This identified a novel homozygous missense mutation in CFHR3 (Ch1:196748315 A/G). Peripheral flow cytometry displayed an expansion in plasma blast and anergic B cells suggesting her immunophenotype displayed a significant antibody response. After 12-months of Eculizumab treatment it was noted her haematological parameters normalized, and a subsequent echocardiogram showed resolution of her heart dysfunction, coinciding with the resolution of her aHUS. 

Conclusion: This case highlights a novel CFHR3 mutation that may confer risk for developing aHUS and related cardiomyopathy. There is future consideration for familial genetic screening for the patient’s offspring, given disease severity. 
 
Author(s): Prianka Puri, Lavinia Petrescu, Matthew Cook, MitaliFadia, Krishna Karpe, Simon Jiang

Abstract Full Text PDF